AlphaFold’s breakthrough reshapes drug discovery and life‑science pipelines, while the proliferation of AI companions raises urgent privacy and regulatory challenges, underscoring the dual impact of generative AI on both scientific advancement and societal risk.
Comments
Want to join the conversation?
Loading comments...